2m 2m 2m 2m 2m 2m 2m
Lifecore Biomed (LFCR)
NASDAQ
$5.68+$0.22 (+4.13%)
Price as of Jun 03, 2026 4:10 PM EDT- $188.3MMarket Cap
- -20.67%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Lifecore Biomed (LFCR)
$5.68+$0.22 (+4.13%)
Annual
Quarterly
12/31/2025 | 05/26/2024 | 05/28/2023 | 05/29/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 43.8M -65.85% | 128.3M +24.20% | 103.3M -44.42% | 185.8M -65.86% | |
Cost of Revenue | 51.8M -40.02% | 86.4M +14.78% | 75.3M -44.41% | 135.4M -70.73% | |
Gross Profit | 23.7M -43.40% | 41.9M +49.54% | 28.0M -44.44% | 50.4M -38.18% | |
Sales and Marketing Expense | 19.5M -51.91% | 40.5M +3.83% | 39.0M -15.52% | 46.1M -29.43% | |
Research and Development Expense | -5.0M -42.10% | -8.6M -1.84% | -8.7M +11.41% | -7.8M -23.29% | |
Depreciation and Amortization Expense | 5.5M -37.45% | 8.9M -33.32% | 13.3M -25.72% | 17.9M -9.98% | |
Total Operating Expenses | 51.8M +2.24% | 50.7M +1.83% | 49.8M -54.34% | 109.0M +14.79% | |
Operating Profit | -733,000 -91.71% | -8.8M -59.42% | -21.8M -62.84% | -58.6M +334.56% | |
Interest Income | 273,000 N/A | N/A N/A | 68,000 -16.05% | 81,000 +68.75% | |
Interest Expense | -1.2M N/A | N/A N/A | -17.6M +1.68% | -17.4M N/A | |
Interest Income and Expense and Net | -953,000 N/A | 0 +100.00% | -17.6M +1.77% | -17.3M -36,091.67% | |
Total Nonoperating Income and Expense | 256,000 +108.39% | -3.1M +163.33% | -1.2M -280.81% | 641,000 +105.48% | |
Income before Taxes | -17.6M -285.24% | 9.5M +114.88% | -63.9M -7.98% | -69.5M +71.67% | |
Income Taxes | 337,000 +84.15% | 183,000 -40.58% | 308,000 +105.18% | -5.9M -23.79% | |
Extraordinary Items | N/A N/A | 5.8M +23.67% | 4.7M N/A | 0 +100.00% | |
Net Income | -18.0M -249.51% | 12.0M +112.07% | -99.6M -13.18% | -114.7M +251.08% | |
Net Income from Continuing Operations Applicable to Common | -18.0M -288.78% | 9.5M +114.88% | -63.9M -7.98% | -69.5M +71.67% | |
Basic EPS and Net Income | -0.54 -235.00% | 0.40 +112.05% | -3.32 -14.87% | -3.90 +248.21% | |
Diluted EPS and Net Income | -0.54 -268.75% | 0.32 +109.64% | -3.32 -14.87% | -3.90 +248.21% | |
Basic Weighted Average Shares | 37.4M +22.63% | 30.5M +1.72% | 30.0M +1.67% | 29.5M +0.59% | |
Diluted Weighted Average Shares | 37.4M +1.94% | 36.7M +22.36% | 30.0M +1.67% | 29.5M +0.59% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 17.5M +106.44% | 8.5M -55.68% | 19.1M +1,061.96% | 1.6M +26.87% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 17.5M +106.44% | 8.5M -55.68% | 19.1M +1,061.96% | 1.6M +26.87% | |
Total Current Assets | 82.3M +1.55% | 81.0M -13.68% | 93.9M -24.12% | 123.7M -16.59% | |
Accumulated Depreciation | 59.2M +17.53% | 50.3M -11.70% | 57.0M +17.44% | 48.5M -52.69% | |
Property and Plant and Equipment and Net | 127.3M -14.33% | 148.6M +10.57% | 134.4M +13.38% | 118.5M -33.99% | |
Total Long-Term Assets | 8.7M +128.59% | 3.8M +30.48% | 2.9M -2.83% | 3.0M -16.87% | |
Total Assets | 232.2M -8.58% | 254.0M +0.16% | 253.5M -8.73% | 277.8M -44.76% | |
Income Taxes Payable | N/A N/A | 543,000 +42.89% | 380,000 +201.59% | 126,000 -97.95% | |
Total Short-Term Debt | 6.3M +711.51% | 773,000 +33.28% | 580,000 -99.58% | 138.2M +376.48% | |
Total Current Liabilities | 23.6M -39.36% | 38.9M -1.06% | 39.3M -77.78% | 176.8M +73.53% | |
Total Long-Term Debt | 5.7M -95.28% | 120.5M +19.24% | 101.1M N/A | 0 -100.00% | |
Total Long-Term Liabilities | 6.7M +31.69% | 5.1M +63.33% | 3.1M +1,538.95% | 190,000 -94.72% | |
Total Liabilities | 198.1M -0.97% | 200.1M -8.42% | 218.5M +16.75% | 187.1M -37.66% | |
Retained Earnings | -223.2M +34.04% | -166.5M -6.73% | -178.5M +134.61% | -76.1M -297.25% | |
Total Stockholders Equity | -14.2M -225.51% | 11.3M +367.49% | -4.2M -104.66% | 90.7M -55.27% | |
Total Shares Outstanding | 37.5M +22.62% | 30.6M +0.79% | 30.3M +2.74% | 29.5M +0.99% | |
Cash Flow | |||||
Cash from Operating Activities | 7.3M +3,477.88% | -217,000 -98.76% | -17.4M -28.52% | -24.4M -262.48% | |
Capital Expenditures | 3.7M N/A | N/A N/A | N/A N/A | 26.2M +10.34% | |
Cash from Investing Activities | 6.3M +135.18% | -17.9M +272.50% | -4.8M -105.88% | 81.8M +853.21% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -4.4M -159.00% | 7.5M -81.09% | 39.7M +169.62% | -57.0M +1,567.77% | |
Financials Ratio | |||||
Gross Margin | -18.35% -156.23% | 32.63% +20.41% | 27.10% -0.05% | 27.11% +81.08% | |
Operating Margin | -1.67% -75.73% | -6.90% -67.33% | -21.11% -33.14% | -31.57% +1,172.83% | |
Return on Assets | -7.39% -256.09% | 4.73% +112.63% | -37.48% +27.57% | -29.38% +369.57% | |
Return on Equity | 1,244.27% +266.92% | 339.11% +247.25% | -230.29% +194.68% | -78.15% +418.96% | |
Revenue Growth | -65.85% -372.11% | 24.20% +154.49% | -44.42% -32.56% | -65.86% +741.48% | |
Current Ratio | 3.49 +67.46% | 2.08 -12.75% | 2.39 +241.47% | 0.70 -51.93% | |
Cash Ratio | 0.74 +240.42% | 0.22 -55.20% | 0.49 +5,124.73% | 0.009 -26.77% | |
Debt-to-Equity Ratio | -0.84 -107.86% | 10.72 +144.61% | -24.03 -1,677.26% | 1.52 +59.33% | |
Debt-to-Assets Ratio | 0.05 -89.22% | 0.48 +19.13% | 0.40 -19.40% | 0.50 +29.03% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow